Cullinan Therapeutics, Inc. (CGEM)
21.83
-0.24
(-1.09%)
USD |
NASDAQ |
Sep 01, 15:42
Cullinan Therapeutics Cash and Short Term Investments (Quarterly) : 334.54M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 334.54M |
| March 31, 2026 | 351.88M |
| December 31, 2025 | 377.90M |
| September 30, 2025 | 332.60M |
| June 30, 2025 | 265.48M |
| March 31, 2025 | 303.83M |
| December 31, 2024 | 398.98M |
| September 30, 2024 | 578.08M |
| June 30, 2024 | 662.50M |
| March 31, 2024 | 433.01M |
| December 31, 2023 | 467.07M |
| September 30, 2023 | 466.43M |
| June 30, 2023 | 491.80M |
| March 31, 2023 | 390.70M |
| Date | Value |
|---|---|
| December 31, 2022 | 467.29M |
| September 30, 2022 | 575.95M |
| June 30, 2022 | 611.00M |
| March 31, 2022 | 410.06M |
| December 31, 2021 | 290.47M |
| September 30, 2021 | 321.04M |
| June 30, 2021 | 336.70M |
| March 31, 2021 | 440.87M |
| December 31, 2020 | 210.21M |
| September 30, 2020 | 94.89M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 98.63M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Rallybio Corp. | 92.85M |
| MapLight Therapeutics, Inc. | 304.72M |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |